Profil
Robert Coutts is currently Director at Achilles Therapeutics UK Ltd. since 2021 and Chief Financial Officer at Achilles Therapeutics Plc since 2020.
Former roles include Financial Controller at Syncona Ltd. from 2015 to 2017 and Accountant at KPMG Audit Plc from 2007 to 2012.
Education includes graduate studies at Bayes Business School and undergraduate studies at New College Oxford.
Aktive Positionen von Robert Coutts
| Unternehmen | Position | Beginn |
|---|---|---|
| ACHILLES THERAPEUTICS PLC | Finanzdirektor/CFO | 01.11.2020 |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Direktor/Vorstandsmitglied | 11.01.2021 |
Ehemalige bekannte Positionen von Robert Coutts
| Unternehmen | Position | Ende |
|---|---|---|
| SYNCONA LIMITED | Comptroller/Controller/Auditor | 01.11.2017 |
KPMG Audit Plc
KPMG Audit Plc Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | 01.07.2012 |
Ausbildung von Robert Coutts
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Syncona Ltd.
Syncona Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Bayes Business School
Bayes Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KPMG Audit Plc
KPMG Audit Plc Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
New College Oxford
New College Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Health Technology |
Achilles Therapeutics Plc
Achilles Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and sells cancer immunotherapies | Health Technology |
















